Amisulpride
  
Side effects 
	
		
Options: 
			
			Show MedDRA Preferred Terms
		
	
	
| Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 4 | 5 | 
| Extrapyramidal disorder | 11% - 33% | 2% |  | x | x | x | x | 
| Hypokinesia | very common |  | x |  |  |  |  | 
| Extrapyramidal symptoms | very common |  | x |  |  |  |  | 
| Akathisia | very common |  | x |  |  |  |  | 
| Insomnia | common, 10% - 11% | 7% | x | x | x | x | x | 
| Anxiety | common, 7% - 9% | 5% | x | x | x | x | x | 
| Dyskinesia | very common, 2% - 6% | 0% | x | x | x | x | x | 
| Endocrine disorder | common |  | x | x | x | x | x | 
| Gastrointestinal disorder | common |  | x | x | x | x | x | 
| Muscle rigidity | very common, 2% - 5% | 2% | x | x | x | x | x | 
| Muscle spasms | common |  | x |  |  |  |  | 
| Trismus | common |  | x |  |  |  |  | 
| Weight increased | common, 2% - 6% | 5% | x | x | x | x | x | 
| Agitation | common, 5% | 3% | x | x | x | x | x | 
| Acute dystonia | common |  | x |  |  |  |  | 
| Constipation | common, 3% - 4% | 1% | x | x | x | x | x | 
| Tremor | very common, 3% - 4% | 6% | x | x | x | x | x | 
| Somnolence | 3% - 4% | 0% | x | x | x | x | x | 
| Headache | 3% | 4% |  | x | x | x | x | 
| Amenorrhoea | 0% - 4% | 0% | x | x | x | x | x | 
| Nausea | common, 2% | 2% | x | x | x | x | x | 
| Nervousness | 2% | 1% |  | x | x | x | x | 
| Salivary hypersecretion | very common, 2% | 0% | x | x | x | x | x | 
| Vomiting | common, 2% | 3% | x | x | x | x | x | 
| Dry mouth | common, 1% - 2% | 1% | x | x | x | x | x | 
| Galactorrhoea | 1% - 3% | 0% | x | x | x | x | x | 
| Depression | 1% - 2% | 0% |  | x | x | x | x | 
| Suicide attempt | 1% - 2% | 0% |  | x | x | x | x | 
| Weight decreased | 1% - 2% | 2% |  | x | x | x | x | 
| Abdominal pain | 1% | 1% |  | x | x | x | x | 
| Diarrhoea | 1% | 1% |  | x | x | x | x | 
| Fatigue | 1% | 1% |  | x | x | x | x | 
| Hypotension | common, 1% | 0% | x | x | x | x | x | 
| Vaginal inflammation | 1% | 0% |  | x | x | x | x | 
| Oculogyric crisis | common, 1% | 0% | x | x | x | x | x | 
| Aggressive reaction | 1% | 1% |  | x | x | x | x | 
| Cardiovascular disorder | uncommon |  | x | x | x | x | x | 
| Hyperglycaemia | uncommon |  | x | x | x | x | x | 
| Hypersensitivity | uncommon |  | x | x | x | x | x | 
| Immune system disorder | uncommon |  | x |  |  |  |  | 
| Movements involuntary | uncommon |  | x | x | x | x | x | 
| Bradycardia | uncommon |  | x | x | x | x | x | 
| Tardive dyskinesia | uncommon |  | x | x | x | x | x | 
| Dizziness | 0% - 1% | 1% |  | x | x | x | x | 
| Dyspepsia | 0% - 1% | 0% |  | x | x | x | x | 
| Hypertension | 0% - 1% | 0% |  | x | x | x | x | 
| Orthostatic hypotension | 0% - 1% | 0% |  | x | x | x | x | 
| Menstrual disorder | 0% - 1% | 0% |  | x | x | x | x | 
| Pruritus | 0% - 1% | 1% |  | x | x | x | x | 
| Skin disorder | 0% - 1% | 1% |  | x | x | x | x | 
| Sweating increased | 0% - 1% | 1% |  | x | x | x | x | 
| Agranulocytosis | postmarketing |  | x |  |  | x | x | 
| Angioedema | postmarketing |  | x | x | x | x | x | 
| Sudden death | postmarketing |  | x | x | x | x | x | 
| Cardiac arrest | postmarketing |  | x | x | x | x | x | 
| Cardiac disorder | postmarketing |  | x |  |  |  |  | 
| Leukopenia | postmarketing |  | x |  |  | x | x | 
| Nervous system disorder | postmarketing |  | x |  |  |  |  | 
| Neuroleptic malignant syndrome | postmarketing |  | x | x | x | x | x | 
| Neutropenia | postmarketing |  | x |  |  | x | x | 
| Pregnancy | postmarketing |  | x |  |  |  |  | 
| Pulmonary embolism | postmarketing |  | x | x | x | x | x | 
| Torsade de pointes | postmarketing |  | x | x | x | x | x | 
| Urticaria | postmarketing |  | x | x | x | x | x | 
| Angiopathy | postmarketing |  | x |  |  |  |  | 
| Ventricular fibrillation | postmarketing |  | x | x | x | x | x | 
| Ventricular tachycardia | postmarketing |  | x | x | x | x | x | 
| Ventricular arrhythmia | postmarketing |  | x | x | x | x | x | 
| Deep vein thrombosis | postmarketing |  | x | x | x | x | x | 
| Drug withdrawal syndrome | postmarketing |  | x |  | x | x | x | 
| Unspecified disorder of skin and subcutaneous tissue | postmarketing |  | x |  |  |  |  | 
| Blood and lymphatic system disorders | postmarketing |  | x |  |  |  |  | 
| Venous thromboembolism | postmarketing |  | x | x | x | x | x | 
| Mental disorder |  |  | x | x | x | x | x | 
| Central nervous system disorder |  |  |  | x | x | x | x | 
| Gynaecomastia |  |  | x | x | x | x | x | 
| Breast pain |  |  | x | x | x | x | x | 
| Neuropathy peripheral |  |  |  | x | x | x | x | 
| Convulsion |  |  | x | x | x | x | x | 
| Malnutrition |  |  | x | x | x | x | x | 
| Erectile dysfunction |  |  | x | x | x | x | x | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 60 | 
|---|
		| Source: | Medsafe | 
|---|
		 
	  
	  
		| Side effects: | 64 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
	  
		| Side effects: | 65 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
	  
		| Side effects: | 68 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
	  
		| Side effects: | 68 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |